Searched for
NOVO NORDISK CYBER INCIDENT
India's GLP-1 boom slows amid price war, weak retentionInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...- WhatsApp 'Boss' Scam: Employees opened a ZIP file sent by 'manager' and lost Rs 3.5 crore; here’s how this dangerous fraud is targeting company officialsWhatsApp Boss Scam: Two Indian companies have collectively lost nearly Rs 3.5 crore in a sophisticated cyber fraud involving malicious zip ...
- China's 360 says it has developed tools to match Anthropic's MythosChina's 360 Security Technology has launched 'Yitian Tulong,' a direct competitor to American AI vulnerability detection systems like Anthr...
- China cybersecurity firm 360 Security Technology claims to have developed tools to match Anthropic's MythosAnthropic Mythos, previewed in April, is a system that detects software vulnerabilities, but cybersecurity experts have warned that it coul...
- Bajaj Auto's systems hit by ransomware attackBajaj Auto confirmed a ransomware attack on Tuesday, affecting its systems and those of its unit, Bajaj Auto Technology. The automotive gia...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- 'Five Eyes' intelligence alliance warns that new AI models pose urgent cyber riskThe intelligence alliance commonly known as the "Five Eyes" said in a three-page statement that, "Frontier AI models are anticipated to e...
- Tata Electronics hit by cyber breach claiming to expose Apple, Tesla trade secretsTata Electronics has confirmed a cybersecurity incident, with ransomware group World Leaks claiming to have posted sensitive design and spe...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Digital systems secure, says Axis Bank amid AI platform-driven vulnerability claims on cybersecurityAxis Bank assures its digital systems are secure. The bank states cyber fraud largely occurs when customers are tricked by external communi...
- JLR pivots to flexible powertrains amid slow pace of electrificationJaguar Land Rover is adjusting its strategy. The company will offer a mix of petrol, hybrid, and electric vehicles. This change comes after...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- European shares rally as Middle East peace hopes drag oil prices lowerEuropean shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...
- Global Market | European stocks rally as oil falls on hopes for US-Iran dealThe benchmark snapped a four-day losing streak on Thursday, as investors digested the European Central Bank's rate hike and largely looked...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Novo Holdings commits 500 million euros in new European tech growth fundNovo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...
Load More
